Patent details

Basic Information

Publication number:

EP4302736

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP232118620

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

OPHTHALMIC IMPLANT FOR DELIVERING THERAPEUTIC SUBSTANCES

French Title of Invention:

IMPLANT OPHTALMIQUE POUR L'ADMINISTRATION DE SUBSTANCES THÉRAPEUTIQUES

German Title of Invention:

OPHTHALMISCHES IMPLANTAT ZUR ABGABE VON THERAPEUTISCHEN SUBSTANZEN

SPC Number:

Dates

Filing date:

27/03/2014

Grant date:

10/06/2026

EP Publication Date:

10/01/2024

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/06/2026

EP B1 Publication Date:

10/06/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

27/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/06/2026

 

 

Name:

ForSight Vision4, Inc.

Address:

1 DNA Way, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:

DOUD, Darren

Address:

United States (US)

2

Name:

ERICKSON, Signe

Address:

United States (US)

3

Name:

CAMPBELL, Randolph, E.

Address:

United States (US)

Priority

Priority Number:

201361806267 P

Priority Date:

28/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61F 9/008; A61F 9/00; A61M 39/02;

Publication

European Patent Bulletin

Issue number:

202624

Publication date:

10/06/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/03/2027

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages